Department of Endocrinology, Barts and the London School of Medicine.
Clin Med (Lond). 2011 Aug;11(4):404-5. doi: 10.7861/clinmedicine.11-4-404.
With the introduction of new drugs and new devices believed to have less potential for systemic effects, the propensity for potent inhaled glucocorticoids to cause potent hypothalamic—pituitary—adrenal axis suppression is still under recognised.
随着新药物和新器械的引入,这些药物和器械被认为对全身影响的潜力较小,但仍未充分认识到强效吸入性糖皮质激素引起强效下丘脑-垂体-肾上腺轴抑制的倾向。